Azria David, Brengues Muriel, Gourgou Sophie, Bourgier Celine
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Montpellier, France.
Université de Montpellier, Montpellier, France.
Front Oncol. 2018 Apr 5;8:83. doi: 10.3389/fonc.2018.00083. eCollection 2018.
While adjuvant treatments of early breast cancers (BCs) had significantly improved patients' overall survival, some of them will still develop locoregional relapses and/or severe late radio-induced toxicities. Here, we propose to review how to personalize locoregional treatment by identifying patients at high and low risk of locoregional relapse, patients at risk of late radio-induced side effects. We will, therefore, discuss how to enhance BC radiosensitivity. Finally, we will address how personalized radiotherapy could be implemented in prospective clinical trials.
虽然早期乳腺癌(BC)的辅助治疗显著提高了患者的总生存率,但其中一些患者仍会出现局部区域复发和/或严重的晚期放射性毒性。在此,我们建议回顾如何通过识别局部区域复发高风险和低风险患者、有晚期放射性副作用风险的患者来实现局部区域治疗的个性化。因此,我们将讨论如何提高乳腺癌的放射敏感性。最后,我们将探讨如何在前瞻性临床试验中实施个性化放疗。